WO1997008190A2 - Compounds - Google Patents

Compounds Download PDF

Info

Publication number
WO1997008190A2
WO1997008190A2 PCT/EP1996/003731 EP9603731W WO9708190A2 WO 1997008190 A2 WO1997008190 A2 WO 1997008190A2 EP 9603731 W EP9603731 W EP 9603731W WO 9708190 A2 WO9708190 A2 WO 9708190A2
Authority
WO
WIPO (PCT)
Prior art keywords
library
compounds
selection
reagents
molecular weight
Prior art date
Application number
PCT/EP1996/003731
Other languages
French (fr)
Other versions
WO1997008190A3 (en
Inventor
Ian Hughes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to EP96930092A priority Critical patent/EP0852583A2/en
Priority to JP9509838A priority patent/JPH11513027A/en
Publication of WO1997008190A2 publication Critical patent/WO1997008190A2/en
Publication of WO1997008190A3 publication Critical patent/WO1997008190A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • C40B50/16Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support involving encoding steps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/005Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00572Chemical means
    • B01J2219/00581Mass
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00592Split-and-pool, mix-and-divide processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes

Definitions

  • the present invention relates to combinatorial chemistry, in particular the synthesis of combinatorial libraries which can be used for the identification of bioactive molecules.
  • library or “combinatorial library” is meant a collection of individual compounds, each compound having a common core structure wherein the library contains a discrete number of independently variable substituents, functional groups or structural elements, and further, wherein the library is designed so that, for the range of chemical moieties selected for each ofthe independently variable substituents, compounds containing all possible permutations of those substituents will be present in the library.
  • a core structure labelled R
  • contains three independently variable substituents, labelled X, Y and Z and if X is taken from m different chemical moieties, Y from n different chemical moieties and Z from/? different chemical moieties (wherein m, n and/?
  • a typical library will typically contain between 2 to 10000 or more compounds, and often more than 10000 compounds.
  • the library can be deconvoluted by an iterative approach, which involves the re-synthesis of mixtures of decreasing complexity until a single compound is identified.
  • sub-libraries can themselves be screened. For example if a main library of 100 components is active, 10 sub-libraries of 10 components can be screened. This approach is advantageous since in a sub-library one of the substituents, i.e. the last substituent to be introduced, can be defmed and kept constant. However the approach has the major disadvantage of being time
  • a single compound, or relatively small number of compounds, are usually identified which have the desired biological activity. This compound can then serve as a lead for the preparation of further structurally related libraries or single compounds.
  • libraries are synthesised on beads
  • a collection of beads are usually screened, and if biological activity is detected the single beads are screened and the active compound identified.
  • mass spectroscopy can be used to identify compounds from single synthesis beads. For example, Chen et al., J. Amer. Chem. Soc. 116, p. 2661 (1994), and Stankova et al., Drug Dev. Res., 33,p.l46 (1994).
  • mass-redundancy a phenomenon known as “mass-redundancy” by which is meant that compounds are indistinguishable on the basis of molecular weight alone. Mass-redundancy may be reduced by measuring molecular weights at higher resolution, when, ultimately, only compounds having identical empirical formulae would be indistinguishable.
  • the present invention is based on the principle that each compound in a library will have, by design, a unique molecular weight which can serve as an identifier for that particular compound.
  • the invention provides a method for the identification of a biologically active compound, and in particular, the identification of a compound derived from a single biologically active bead.
  • the advantages of this method over tagging synthesis beads are firstly the present invention does not impose any restrictions on the nature ofthe chemistry used to synthesise the combinatorial library, since it does not have to be compatible with tagging chemistry and does not introduce additional non-productive synthetic steps, and secondly by using the present invention the compound can, if so required, be identified without association with the bead of origin.
  • An additional advantage is the ability to identify the compound by its nominal mass without recourse to high resolution mass spectrometry. Of course, although not necessary for identification, high resolution measurements and analysis of fragmentation patterns remain available options for further confimatory evidence.
  • the present invention provides a method for the control of mass redundancies in a combinatorially synthesised compound library which comprises identifying compounds by their molecular weight
  • molecular weight is determined by mass spectrometry.
  • the above method is used to identify compounds derived from a single bead.
  • the present invention allows for the deliberate incorporation ofthe natural isotopic mass patterns of chorine and bromine atoms or other artificially isotopically enriched atoms or molecules, to further extend its scope and usefulness. It will be apparent to those skilled in the art that a structure designed by the method of this invention can be unambiguously characterised by determining its nominal mass and isotope pattern.
  • the present invention relies on a selection strategy which is based on the following observation.
  • a selection strategy which is based on the following observation.
  • Combinatorial libraries may be defined as mixtures of related compounds having a common "core" structure which bears substituent groups (or R-groups) at a number of positions.
  • the common core structure might be the peptide backbone, and the varying R-groups would represent the amino acid side-chains.
  • the common core structure might be a multiply substituted ring system, for example a para-dianilide, with varying R-groups possibly derived from a range of different acylating agents.
  • the above method can be applied to substituent group selection by mapping the nominal molecular weights of available substituent groups onto tables of varying numbers of columns.
  • the charts so generated are defined as having a "periodicity" equal to the number of columns. Different charts may be envisaged for different reagent types (e.g. R-COC1, R-NCO).
  • the selection of sets of substituent groups must follow the following three rules.
  • Rule 1 and Set 2 should be chosen from charts ofthe same periodicity.
  • Members of Set 1 should all be chosen from the same column (and be of different masses).
  • Members of Set 2 should all be chosen from different columns. It is convenient, although by no means necessary, to map only the varying R-group ofthe reagents, i.e. the R of R-COCl, R-NCO, HO2CH(R)NH2, since the remainder ofthe group adds a constant mass and may be regarded as part ofthe core structure ofthe library. In the case of groups containing Cl and Br, only the lowest isotopic weight (35 or 79 respectively) is used.
  • the amino acids make a convenient sized data set to illustrate features ofthe method.
  • Set 1 (same column) may contain up to 4 groups,(e.g. Gly, Ser, His, Phe) and Set 2 (different columns) up to 8 (e.g. Gly, Lys, Val, Met, Leu, Asn, Asp, Trp). Hence a total of 32 unique dipeptides could be generated. Ifthe excercise is repeated with a 16 column table, Chart 3 is produced (after simplification).
  • Non-peptide libraries are generally non-oligomeric and often consist of a core structure bearing a number of substituent groups.
  • substituent groups are derived from sets of similar reagents.
  • R 1 and R 2 might be derived from the acid chloride reagents R'COCI and R 2 COCl.
  • Chart 4 shows the R-groups of a small selection of acid chlorides mapped to their nominal molecular weights on a periodicity 10 chart, according to the method of this invention. The groups are labelled with their nominal molecular weight suffixed with a letter to distinguish isobaric groups. The use of Chart 4 to select sets of substituents for use in combinatorial libraries is exemplified below.
  • Chart 4 shows that up to ten groups of different nominal mass may be selected from column 7, for example, the groups labelled 27a, 57a, 67a, 77a, 87a, 107a, 117a, 127a, 137a, and 147a. Numerous smaller sets could be selected from this and other columns of Chart 4.
  • Rule 4 Either, but not both, of Rules 2 and 3 may be replaced by Rules 5 and 6 respectively.
  • Rule 7 Exclude groups containing Cl and Br from Sets 1 and 2. Members of Set 3 should be selected freely provided that each member contains different numbers of Cl and Br atoms or other atoms distinguishable by their isotope patterns.
  • Rule 7 forces Set 3 to contain mostly halogenated groups.
  • the selection rules, Rule 1 to Rule 3 may be represented mathematically.
  • the method requires that all numerical values used (molecular weight, periodicity, multiples and remainders) are integer values.
  • the periodicity, P corresponds to the number of columns in the graphical method.
  • Rule 1 Set 1 and Set 2 are selected using the same value of P in Rule 2 and Rule 3 respectively.
  • the invention provides a library synthesised using the above method, rules or algorithm and the use ofthe method, rules or algorithm for the synthesis of a chemical library.
  • the polymer-bound lysine derivative from Description 1 (220 mg, 0.15 mmol) was washed with DCM (2x15 ml) and DMF (2x20 ml) then treated with 20% piperidine in DMF (2x20 ml) for 1 and 20 min.
  • the resin was washed with DMF (2x15 ml) and DCM (2x15 ml), then treated for 4 hours with triethylamine (0.42 ml, 3 mmol) and one ofthe acid chlorides listed in Table 1 (1.5 mmol) in DCM (15 ml).
  • the polymer-bound lysine derivative from Description 2 (140 mg, approx. 0.1 mmol) was washed with DCM (2x15 ml), then treated with 30% trifluoroacetic acid and 2% anisole in DCM (2x15 ml) for 1 and 30 min.
  • the resin was washed with DCM (3x15 ml), 10% triethylamine in DCM (2x10 ml), then was treated for 4 h with triethylamine (0.28 ml, 2 mmol) and one of the acid chlorides listed in Table 2 (1 mmol), in DCM (15 ml).
  • the resin was washed with DMF (15 ml) and DCM (3x15 ml) and finally methanol (15 ml) to give the title compounds, D3, as fourteen mixtures each often polymer-bound components.
  • a suspension of polymer-bound triphenylphosphine prepared from 150-200 um
  • the polymer-bound phosphonium salt from Description 4 (385 mg, 0.35 meq) was washed with DCM (2x25 ml), then treated with a mixture of 30% trifluoroacetic acid and 2% anisole in DCM (2x25 ml) for 1 and 30 min.
  • the resin was washed with DCM (3x25 ml), 10% triethylamine in DCM (2x25 ml) and DCM (2x25 ml).
  • the resin was suspended overnight in a solution of 1 -hydroxy-7-azabenzotriazole (109 mg, 0.8 mmol), 1,3- diisopropylcarbodiimide (0.13 ml, 0.8 mmol) and one ofthe carboxylic acids listed in Table 4 (0.75 mmol) in DMF (10 ml) and DCM (3 ml). After washing with DMF (2x25 ml) and DCM (3x25 ml), the five products were combined as a slurry in DCM, filtered and treated with 20% piperidine in DMF (2x30 ml) for 1 and 30 min. The resin was washed with DMF (2x30 ml) and DCM (3x30 ml), then dried to give the title compounds, D5 (1.83 g, approx 1.75 mmol) as a mixture of five polymer-bound components..
  • the polymer-bound phosphonium salt from Description 5 (160 mg, approx 0.17 mmol) was suspended in DCM (10 ml) and treated with triethylamine (0.1 ml, 0.7 mmol) and one ofthe acid chlorides listed in Table 5 (0.35 mmol). After 90 min the resin was filtered and washed with DCM (2x20 ml). The ten products were combined as a slurry in DCM and washed with DMF (3x30 ml) and DCM (2x30 ml). The resin was finally washed successively with 3:1, 1:1 and 1 :3 mixtures of DCM and ether, and then with ether alone to give the title compounds, D6, as a mixture of 50 polymer-bound components.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Structural Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention relates to combinatorial chemistry, in particular synthesis of combinatorial libraries.

Description

COMPOUNDS
The present invention relates to combinatorial chemistry, in particular the synthesis of combinatorial libraries which can be used for the identification of bioactive molecules.
In recent years, there has been a growing demand for the production and identification of small molecules that have pharmacological activity as, for example, agonists or antagonists of various cellular acceptor molecules, such as cell-surface receptors, enzymes or antibodies. Historically, the process to identify pharmacologically active molecules has been characterised by the preparation of single compounds followed by biological testing, which is time-consuming, labour intensive and inefficient.
In an effort to reduce the time and expense involved in screening a large number of randomly chosen compounds for biological activity, several developments have been made in using peptides or nucleotides combined with solid phase synthesis to provide libraries of compounds for the discovery of lead compounds. See, for example, Lebl et al., Int. J. Pept. Prot. Res., 41, p. 201 (1993) which discloses methodologies providing selectively cleavable linkers between peptide and resin such that a certain amount of peptide can be liberated from the resin and assayed in soluble form while some ofthe peptide still remains attached to the resin, where it can be sequenced; Lam et al, Nature, 354, p. 82 (1991) and WO 92/00091 which disclose a method of synthesis of linear peptides on a solid support such as polystyrene or polyacrylamide resin; Geysen et al., J. Immunol. Meth., 102, p. 259 (1987) which discloses the synthesis of peptides on derivatized polystyrene pins which are arranged on a block in such a way that they correspond to the arrangement of wells in a 96-well microtiter plate; and Houghten et al., Nature, 354, p. 84 (1991) and WO 92/09300 which disclose an approach to de novo determination of antibody or receptor binding sequences involving soluble peptide pools.
By the term "library" or "combinatorial library" is meant a collection of individual compounds, each compound having a common core structure wherein the library contains a discrete number of independently variable substituents, functional groups or structural elements, and further, wherein the library is designed so that, for the range of chemical moieties selected for each ofthe independently variable substituents, compounds containing all possible permutations of those substituents will be present in the library. Thus, if a core structure, labelled R, contains three independently variable substituents, labelled X, Y and Z, and if X is taken from m different chemical moieties, Y from n different chemical moieties and Z from/? different chemical moieties (wherein m, n and/? are integers which define the size of the library, and which range between 1 to 1000; preferably between 1 to 100; most preferably between 1 to 20), then the library would contain m n xp different chemical compounds and all possible combinations of X, Y and Z would be present on the core structure R within that library. A typical library will typically contain between 2 to 10000 or more compounds, and often more than 10000 compounds.
Once the library of compounds has been synthesised and screened there must be some method to deconvolute the results of screening such that individual active compounds can be identified. Many methods of deconvolution are possible. For example the library can be deconvoluted by an iterative approach, which involves the re-synthesis of mixtures of decreasing complexity until a single compound is identified. In particular, sub-libraries can themselves be screened. For example if a main library of 100 components is active, 10 sub-libraries of 10 components can be screened. This approach is advantageous since in a sub-library one of the substituents, i.e. the last substituent to be introduced, can be defmed and kept constant. However the approach has the major disadvantage of being time
After deconvolution ofthe library, a single compound, or relatively small number of compounds, are usually identified which have the desired biological activity. This compound can then serve as a lead for the preparation of further structurally related libraries or single compounds. In the case where libraries are synthesised on beads, a collection of beads are usually screened, and if biological activity is detected the single beads are screened and the active compound identified.
It will be apparent that the identification of a biologically active compound from a complex mixture is time consuming and presents certain difficulties. Therefore there is a need for improved methods for efficiently identifying pharmaceutically active compounds prepared as libraries.
One approach to this problem is the concept of "tagging" synthesis beads by the introduction of chemical "tags" at each synthetic step during the construction ofthe library. The nature ofthe chemical tags on a particular synthesis bead thus defines the synthetic history of that bead and facilitates structure determination. See, for example, Kerr et al., J. Amer. Chem. Soc, 115, p. 2529 (1993) which discloses the use of peptide coding strands, which can be "read" by Edman sequencing, and Ohlmeyer et al., Proc . Natl. Acad. Sci., 90, p. 10922 (1993) which discloses molecular tags which can be "read" by electron capture capillary gas chromatography. A key requirement for compound identification using tagged beads is that the compound must remain bound to or associated with its bead of origin throughout the screening procedure.
Certain screening strategies may rely on the separation of biologically active compounds from soluble mixtures. For example, Chu et al, J Amer. Chem. Soc.lll, p.5419 (1995) disclose the use of affinity capillary electrophoresis for the separation from combinatorial libraries of those ligands that bind most tightly to a receptor. In such screening strategies any former association of a compound with its bead of origin, and hence structural information contained in "tags", would be lost.
It is also established that mass spectroscopy can be used to identify compounds from single synthesis beads. For example, Chen et al., J. Amer. Chem. Soc. 116, p. 2661 (1994), and Stankova et al., Drug Dev. Res., 33,p.l46 (1994). However, when large numbers of compounds are present in a combinatorial library it is highly likely that many will have the same nominal molecular weights. This leads to a phenomenon known as "mass-redundancy" by which is meant that compounds are indistinguishable on the basis of molecular weight alone. Mass-redundancy may be reduced by measuring molecular weights at higher resolution, when, ultimately, only compounds having identical empirical formulae would be indistinguishable.
The present invention is based on the principle that each compound in a library will have, by design, a unique molecular weight which can serve as an identifier for that particular compound. The invention provides a method for the identification of a biologically active compound, and in particular, the identification of a compound derived from a single biologically active bead. The advantages of this method over tagging synthesis beads are firstly the present invention does not impose any restrictions on the nature ofthe chemistry used to synthesise the combinatorial library, since it does not have to be compatible with tagging chemistry and does not introduce additional non-productive synthetic steps, and secondly by using the present invention the compound can, if so required, be identified without association with the bead of origin. The fact that tagging is not required is clearly advantageous. An additional advantage is the ability to identify the compound by its nominal mass without recourse to high resolution mass spectrometry. Of course, although not necessary for identification, high resolution measurements and analysis of fragmentation patterns remain available options for further confimatory evidence.
The present invention provides a method for the control of mass redundancies in a combinatorially synthesised compound library which comprises identifying compounds by their molecular weight Preferably molecular weight is determined by mass spectrometry. Preferably the above method is used to identify compounds derived from a single bead.
In situations where two or more compounds have identical nominal molecular mass, the present invention allows for the deliberate incorporation ofthe natural isotopic mass patterns of chorine and bromine atoms or other artificially isotopically enriched atoms or molecules, to further extend its scope and usefulness. It will be apparent to those skilled in the art that a structure designed by the method of this invention can be unambiguously characterised by determining its nominal mass and isotope pattern.
The invention will now be explained and exemplified in detail.
1. Background to the invention
The present invention relies on a selection strategy which is based on the following observation. When consecutive integers are arrayed in a table of c columns and r rows in the manner exemplified below, and two sets of numbers are selected such that Set 1 comprises numbers all from the same column (maximum set size r), and Set 2 comprises numbers each selected from different columns (maximum set size c), the addition of any pair of numbers, one chosen from each set, will generate a sum which differs from that created by any other similar pairwise combination, giving a maximum of (r x c) unique combinations.
Example 1.1 Array of 100 integers (c=10 and r=10)
1 2 3 A 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60
61 62 63 64 65 66 67 68 69 70
71 72 73 74 75 76 77 78 79 80
81 82 83 84 85 86 87 88 89 90
91 92 93 94 95 96 97 98 99 100
The largest sets that can be selected from this table each contain 10 numbers, and the pairwise addition of two such sets, Set 1 (same column) in italic, Set 2 (different columns) in bold is shown below. It is clear by inspection that all sums are unique. For this particular selection, the 100 unique values fall in the range 12 to 188. It is also apparent that the same number (in this case 23) may occur in both sets.
Seti+Set2 31 32 23 64 95 86 17 28 9 90
3 34 35 26 67 98 89 20 31 12 93
13 44 45 36 77 108 99 30 41 22 103
23 54 55 46 87 118 109 40 51 32 113
33 64 65 56 97 128 119 50 61 42 123
43 74 75 66 107 138 129 60 71 52 133
53 84 85 76 117 148 139 70 81 62 143
63 94 95 86 127 158 149 80 91 72 153
73 104 105 96 137 168 159 90 101 82 163
83 114 115 106 147 178 169 100 111 92 173
93 124 125 116 157 188 179 110 121 102 183
Example 1.2 Array of 78 integers (c=13 and r=6)
1 2 3 A 5 6 7 8 9 10 11 12 13
14 15 16 17 18 19 20 21 22 23 24 25 26
27 28 29 30 31 32 33 34 35 36 37 38 39
40 41 42 43 44 45 46 47 48 49 50 51 52
53 54 55 56 57 58 59 60 61 62 63 64 65
66 67 68 69 70 71 72 73 74 75 76 77 78
This table illustrates the effect of altering the number of columns (c), namely that as c varies, different integers are brought into alignment within a given column. The significance of this observation will be explained later.
The pairwise addition of two sets chosen from this 13 x 6 table is shown below and gives rise to 78 unique values in the range 5 to 145.
5et/+Set2 14 2 3 56 31 45 46 8 74 49 11 77 52
3 17 5 6 59 34 48 49 11 77 52 14 80 55
16 30 18 19 72 47 61 62 24 90 65 27 93 68
29 43 31 32 85 60 74 75 37 103 78 40 106 81
42 56 44 45 98 73 87 88 50 116 91 53 119 94
55 69 57 58 111 86 100 101 63 129 104 66 132 107
68 82 70 71 123 99 113 114 76 142 117 79 145 120 2. Application of method to selection of combinatorial library substituents
Combinatorial libraries may be defined as mixtures of related compounds having a common "core" structure which bears substituent groups (or R-groups) at a number of positions.
Figure imgf000008_0001
Within an individual library, all components have the same core structure, but have different substituent groups at one or more positions. Thus in a library of dipeptides, the common core structure might be the peptide backbone, and the varying R-groups would represent the amino acid side-chains.
Figure imgf000008_0002
In a typical non-peptide library the common core structure might be a multiply substituted ring system, for example a para-dianilide, with varying R-groups possibly derived from a range of different acylating agents.
Figure imgf000008_0003
The above method can be applied to substituent group selection by mapping the nominal molecular weights of available substituent groups onto tables of varying numbers of columns. The charts so generated are defined as having a "periodicity" equal to the number of columns. Different charts may be envisaged for different reagent types (e.g. R-COC1, R-NCO). The selection of sets of substituent groups must follow the following three rules.
Rule 1. Set 1 and Set 2 should be chosen from charts ofthe same periodicity. Rule 2. Members of Set 1 should all be chosen from the same column (and be of different masses). Rule 3. Members of Set 2 should all be chosen from different columns. It is convenient, although by no means necessary, to map only the varying R-group ofthe reagents, i.e. the R of R-COCl, R-NCO, HO2CH(R)NH2, since the remainder ofthe group adds a constant mass and may be regarded as part ofthe core structure ofthe library. In the case of groups containing Cl and Br, only the lowest isotopic weight (35 or 79 respectively) is used.
Example 2.1 A small data set: the natural amino acids
The amino acids make a convenient sized data set to illustrate features ofthe method. The 19 amino acid side chains (excluding proline) denoted by the standard three- letter code of their parent amino acid, are mapped to their masses in Chart 1.
Chart 1. Amino acid side chains, periodicity 10
Figure imgf000009_0001
Because the rules involve selection from columns, the chart produced can be much simplified by ignoring the mass numbers and condensing the columns. Isobaric groups are shown on the same line (Gln/Lys and Leu/Ile) - clearly only one from each pair may be chosen.
Chart 2. Amino acid side chains, periodicity 10
Gly Gln/Lys Val Ala Cys Asn Asp Arg
Ser Glu Thr Leu/Ile T
His Met Tyr
Phe
Set 1 (same column) may contain up to 4 groups,(e.g. Gly, Ser, His, Phe) and Set 2 (different columns) up to 8 (e.g. Gly, Lys, Val, Met, Leu, Asn, Asp, Trp). Hence a total of 32 unique dipeptides could be generated. Ifthe excercise is repeated with a 16 column table, Chart 3 is produced (after simplification).
Chart 3. Amino acid side chains, periodicity 16
Figure imgf000010_0001
In this case up to 5 (Setl) x 9 (Set 2) = 45 unique nominal mass dipeptides could be generated.
Some general points can be observed from the above charts:
• The choice of substituent group is most limited for Set 1 chosen from the same column. In the case of Chart 2, there is only one way to select four substituents in a single column, i.e. Gly, Ser, His, Phe (Column 1). If only three groups were required, then 7 permutations would be possible, e.g. Gly, Ser, Phe (Column 1) or Cys, Leu, Tyr (Column 7).
• The number of permutations for choosing from different columns is considerable, in the case of Chart 2 it is 4x2x2x3x4x1x1x2 = 384. • Changing the initial number of columns brings quite different sets of substituents into alignment, (e.g. Ala, Thr, Met in Chart 2 and Ala, Ser, Cys in Chart 3) Example 2.2 Application of a larger data set to non-peptide libraries
Non-peptide libraries are generally non-oligomeric and often consist of a core structure bearing a number of substituent groups. Typically the substituent groups are derived from sets of similar reagents. For example, one or both ofthe groups R1 and R2 might be derived from the acid chloride reagents R'COCI and R2COCl.
Figure imgf000011_0001
A large number of acid chlorides are known in the chemical literature and many are available commercially. Chart 4 shows the R-groups of a small selection of acid chlorides mapped to their nominal molecular weights on a periodicity 10 chart, according to the method of this invention. The groups are labelled with their nominal molecular weight suffixed with a letter to distinguish isobaric groups. The use of Chart 4 to select sets of substituents for use in combinatorial libraries is exemplified below.
Selection of Set 1 using Rule 2 (selection from the same column).
Inspection of Chart 4 shows that up to ten groups of different nominal mass may be selected from column 7, for example, the groups labelled 27a, 57a, 67a, 77a, 87a, 107a, 117a, 127a, 137a, and 147a. Numerous smaller sets could be selected from this and other columns of Chart 4.
Selection of Set 2 using Rule 3 (selection from different columns)
A maximum often groups may be selected from different columns of Chart 4, since this is the number of columns in the chart (periodicity = 10). Many such sets could be selected, for example a set comprising the groups labelled 71a, 102a, 83a, 174a, 145a, 136a, 127a, 78a, 69a and 170a.
In combination with a suitable core structure Sets 1 and 2 above would give 10 x 10 = 100 compounds of different nominal mass. Chart 4. Selection of acid chloride substituent groups, periodicity 10
Figure imgf000012_0001
Figure imgf000013_0001
Figure imgf000014_0001
3. Use of isotope patterns to extend scope of the method.
If two compounds have the same nominal mass (M), but contain different numbers of Cl and Br atoms, they may be distinguished by their M+2, M+4, etc. isotope patterns. Hence the selection rules may be extended as follows.
Rule 4. Either, but not both, of Rules 2 and 3 may be replaced by Rules 5 and 6 respectively.
Rule 5. Members of Set 1 should be chosen from the same column and may have the same mass provided that the isotope pattern (ie. Cl, Br count) is different.
Rule 6. Members of Set 2 should be chosen from any columns provided that all members chosen from an individual column have different isotope patterns (ie. different Cl, Br counts).
Example 3.1 Application of Rule 5 to extend Set 1
Inspection of column 7 of Chart 4 shows that all three groups at mass 117, i.e. groups (117a, 117b and 117c) may now be included since they contain 0, 1 and 3 chlorine atoms respectively. Similarly groups 147a and 147b with 0 and 1 chlorine atoms respectively may be included. In contrast, groups 127a and 127b may not both be included since they are isobaric and cannot be distinguished by their isotope content. The modified set, Set la contains 13 groups, namely 27a, 57a, 67a, 77a, 87a, 107a, 117a, 117b, 117c, 127a, 137a, 147a and 147b. In combination with Set 2, this modified set would give rise to 13 x 10 = 130 distinguishable compounds.
12 Example 3.2 Application of Rule 6 to extend Set 2
Examination of column 1 of Chart 4 reveals that group I l ia may be used in addition to the previously selected group 71a since the groups contain 1 and 0 chlorine atoms respectively. Similarly in column 5, groups 125a (1 chlorine), 145b (2 chlorines) and 155a (1 bromine) may be added, as can groups 117b (1 chlorine) and 117c (3 chlorines) from column 7. The modified set, Set 2a contains 16 groups, namely 71a, I l ia, 102a, 83a, 174a, 145a,125a, 145b, 155a, 136a, 127a, 117b, 1 17c, 78a, 69a and 170a. In combination with Set 1 , this modified set would give rise to 10 x 16 = 160 distinguishable components.
4. Extension of method to further dimensions.
The rules described so far allow two sets of substituents to be chosen which in combination give uniquely "self-coded" products. Set sizes of 10 are easily achieved, and diverse set sizes of up to 20 are not unrealistic. If a library contains a core structure with three variable sites, this can be accommodated by chosing the third set of substituents freely, and keeping the products as separate sublibraries, ie. the third variable is defined by its sublibrary. Since most assay systems involve some kind of partitioning (e.g. into wells) or spreading (e.g. over melanophore plates), there is little to be gained by mixing the sublibraries, compared to the structural information that would be lost in so doing. If Set 3 is of a similar size to Sets 1 and 2, it is clear that self-coded libraries in the range 1000 (10x10x10) to 8000 (20x20x20) components can be designed.
If a core structure contains four variable sites a further coding stage is required, ie. Sets 1, 2 and 3 coded, Set 4 as sublibraries. Selection of a third set of substituents may be made following Rule 7 below.
Rule 7. Exclude groups containing Cl and Br from Sets 1 and 2. Members of Set 3 should be selected freely provided that each member contains different numbers of Cl and Br atoms or other atoms distinguishable by their isotope patterns.
Example 4.1 Application of Rule 7 to Chart 4
The unmodified ten substituent sets, Set 1 and Set 2, selected by Rules 2 and 3 above, are suitable since neither contains chlorinated or brominated groups. A possible selection for Set 3 would comprise groups 69b (0 halogens), 11 la (1 chlorine), 145b (2 chlorines), 117c (3 chlorines) and 155a (1 bromine). In combination with an appropriate core structure, Sets 1 , 2 and 3 would give a total of 10 x 10 x 5 = 500 components distinguishable by their nominal mass and isotopic mass patterns.
The application of Rule 7 forces Set 3 to contain mostly halogenated groups.
However, further reagents containing artificially isotopically enriched substituents could be incorporated. For example, mixing CH3COCI and CD3COCI would give a substituent methyl group with nominal mass (M) 15 and isotopic mass at M+3.
It will be appreciated that in certain circumstances, especially in the case of smaller libraries, minor departures from any ofthe above rules may still provide libraries with zero or little mass redundancy.
5. Mathematical representation of the selection method
In additon to the graphical representation ofthe selection method using charts as described above, the selection rules, Rule 1 to Rule 3 may be represented mathematically.
The method requires that all numerical values used (molecular weight, periodicity, multiples and remainders) are integer values.
The periodicity, P corresponds to the number of columns in the graphical method.
The selection rules may now be expressed thus.
Rule 1. Set 1 and Set 2 are selected using the same value of P in Rule 2 and Rule 3 respectively.
Rule 2. Members of Set 1 are chosen such that all members have different molecular weights, and that these weights each give the same remainder (rem) when divided by P.
Rule 3. Members of Set 2 are chosen such that all members have different molecular weights, and that these weights each give a different remainder (rem) when divided by P.
Since the method described can be expressed in a mathematical form, the method can be incorporated into a computer program by means of an appropriate algorithm. Such a computerised implementation ofthe method falls within the scope of this patent which in a further aspect provides a computer-based method for selection of reagents to construct a combinatorial library of compounds each having a unique molecular weight or isotope pattern, comprising the steps of:
a) selection, from databases of reagents, of those reagents suitable for the desired chemical transformation;
b) distinguishing substituent groups within each reagent structure and calculating the molecular weight and isotope pattern of each substituent group;
c) mapping the substituent groups according to their molecular weight into a chart format following the procedures described herein; and
d) allowing selection of reagents from the charts, either by manual selection or by an automated process according to the Rules described herein, and subsequent transfer ofthe reagents to an experimental worksheet for implementation of a manual or automated synthesis ofthe combinatorial library.
In a further aspect the invention provides a library synthesised using the above method, rules or algorithm and the use ofthe method, rules or algorithm for the synthesis of a chemical library.
The following examples illustrate the invention.
Example 5. Synthesis and analysis of a library with 140 distinguishable components (E5)
Figure imgf000018_0001
Description 1: Polymer-bound N(alpha)-FMOC-N(epsilon)-BOC-(S)-lysine (Dl)
A solution of N(alpha)-FMOC-N(epsilon)-BOC-(S)-lysine (21.5 g, 44.8 mmol) in DCM (250 ml) was treated with 1,3 -diisopropyl carbodiimide (5.65 g, 44.8 mmol) and DMAP (0.25 equivalents). After 30 min at room temperature, the solution was added to a suspension of 100-200 mesh hydroxymethyl polystyrene (10 g, 10 mmol) in DMF (50 ml). After agitating for 2.5 h the resin was washed well with DMF and DCM, then dried, to give the title compound, Dl .
Description 2: Mixture of polymer-bound N(alpha)-acyl-N(epsilon)-BOC-(5)- lysines (D2)
In ten separate experiments, the polymer-bound lysine derivative from Description 1 (220 mg, 0.15 mmol) was washed with DCM (2x15 ml) and DMF (2x20 ml) then treated with 20% piperidine in DMF (2x20 ml) for 1 and 20 min. The resin was washed with DMF (2x15 ml) and DCM (2x15 ml), then treated for 4 hours with triethylamine (0.42 ml, 3 mmol) and one ofthe acid chlorides listed in Table 1 (1.5 mmol) in DCM (15 ml). The resin was washed with DMF (2x15 ml) and DCM (2x15 ml) then the portions were combined as a slurry in methanol and washed well with DCM to give the title compounds, D2 (2.14 g, approx 1.5 mmol) as a mixture of ten polymer-bound components.
Description 3: Mixtures of polymer-bound N(alpha)-acyI-N(epsilon)-acyl-(S)- lysines (D3)
In fourteen separate experiments, the polymer-bound lysine derivative from Description 2 (140 mg, approx. 0.1 mmol) was washed with DCM (2x15 ml), then treated with 30% trifluoroacetic acid and 2% anisole in DCM (2x15 ml) for 1 and 30 min. The resin was washed with DCM (3x15 ml), 10% triethylamine in DCM (2x10 ml), then was treated for 4 h with triethylamine (0.28 ml, 2 mmol) and one of the acid chlorides listed in Table 2 (1 mmol), in DCM (15 ml). The resin was washed with DMF (15 ml) and DCM (3x15 ml) and finally methanol (15 ml) to give the title compounds, D3, as fourteen mixtures each often polymer-bound components.
Analysis of libraries (E5) by Mass Spectroscopy
Individual beads were taken from libraries of Description 3 and treated with 50% n- propylamine in DCM (50 ul) for 6h. The reagents were allowed to evaporate, to give individual members of Example 5. Representative results of LC-MS analysis, along with the assignment ofthe molecular ions detected are given in Table 3.
TABLE 1
Figure imgf000020_0001
TABLE 2
Figure imgf000021_0001
TABLE 2 cont'd
Figure imgf000022_0001
TABLE 3
Assignment
M+H (found) Rl (TABLE 1) R? (TABLE 2) MASS (calc)
527 J C 526
428 E L 427
488 J L 487
362 D F 361
548/550 (1 :1) I M 547/549(1 :1)
446/451(1:1) G G 445/450(1:1)
Example 6. Synthesis and analysis of a library with 50 distinguishable components (E6)
Figure imgf000023_0001
Description 4: Polymer-bound 3-[N,N-di(t-butyloxycarbonyl)- aminomethyl] benzyl triphenylphosphonium bromide (D4)
A suspension of polymer-bound triphenylphosphine prepared from 150-200 um
4-bromopolystyrene by the method of Bernard and Ford (J. Org. Chem. 1983, 48, 326) (2.96 g, approx 5 meq) in DMF (25 ml) was treated with N,N-di(t-butyloxycarbonyl)-3- bromomethylbenzylamine (4 g, 10 mmol). The mixture was heated at 70 °C for 48 h, cooled, filtered and the polymer was washed alternately with toluene (50 ml) and DCM (50 ml) (3 times), then DCM (50 ml) and ether (50 ml) (3 times), and finally with 1 : 1 DCM/ether (50 ml) and ether (2x50 ml) to give the title compound, D4 (4.21 g).
Description 5: Mixture of polymer-bound 3-[N-(aminoacyl)aminomethyl]benzyl triphenylphosphonium salts (D5)
In five separate experiments, the polymer-bound phosphonium salt from Description 4 (385 mg, 0.35 meq) was washed with DCM (2x25 ml), then treated with a mixture of 30% trifluoroacetic acid and 2% anisole in DCM (2x25 ml) for 1 and 30 min. The resin was washed with DCM (3x25 ml), 10% triethylamine in DCM (2x25 ml) and DCM (2x25 ml). The resin was suspended overnight in a solution of 1 -hydroxy-7-azabenzotriazole (109 mg, 0.8 mmol), 1,3- diisopropylcarbodiimide (0.13 ml, 0.8 mmol) and one ofthe carboxylic acids listed in Table 4 (0.75 mmol) in DMF (10 ml) and DCM (3 ml). After washing with DMF (2x25 ml) and DCM (3x25 ml), the five products were combined as a slurry in DCM, filtered and treated with 20% piperidine in DMF (2x30 ml) for 1 and 30 min. The resin was washed with DMF (2x30 ml) and DCM (3x30 ml), then dried to give the title compounds, D5 (1.83 g, approx 1.75 mmol) as a mixture of five polymer-bound components..
Description 6: Mixture of polymer-bound 3-[N- (acylaminoacyl)aminomethyl] benzyl triphenylphosphonium salts (D6)
In ten separate experiments, the polymer-bound phosphonium salt from Description 5 (160 mg, approx 0.17 mmol) was suspended in DCM (10 ml) and treated with triethylamine (0.1 ml, 0.7 mmol) and one ofthe acid chlorides listed in Table 5 (0.35 mmol). After 90 min the resin was filtered and washed with DCM (2x20 ml). The ten products were combined as a slurry in DCM and washed with DMF (3x30 ml) and DCM (2x30 ml). The resin was finally washed successively with 3:1, 1:1 and 1 :3 mixtures of DCM and ether, and then with ether alone to give the title compounds, D6, as a mixture of 50 polymer-bound components.
Analysis of library (E6) by mass spectroscopy.
Individual beads from Description 6 were treated with a 10 mM solution of sodium hydroxide in 10% aqueous dioxane (50 ul) overnight to effect cleavage to the individual members of Example 6. Representative results of APCI-MS analysis, along with the assignment ofthe molecular ions detected are given in Table 6.
TABLE 4
Figure imgf000025_0001
Figure imgf000026_0001
TABLE 6
ASSIGNMENT
M+H (found) Rl (TABLE 3) R2 (TABLE 4) MASS (calc)
365 C D 364
329 C B 328
379 E C 378
439 E H 438
391 E D 390
409 D F 408
329 C B 328
457 D J 456
325 D A 324
357 A H 356
403 E E 402
397 D E 396
433 D H 432
359 B G 358
353 C C 352
325 D A 324
403 E E 402
427 E G 426

Claims

CLAIMS:
1. A method for the control of mass redundancies in a combinatorially synthesised compound library which comprises identifying compounds by their molecular weight.
2. The method according to claim 1 where molecular weight is determined by mass spectrometry.
3. A library of compounds designed and synthesised using the method of claim l or 2.
4. Use ofthe method according to claim 1 or 2 for the design and synthesis of a chemical library.
5. A computer-based method for selection of reagents to construct a combinatorial library of compounds each having a unique molecular weight or isotope pattern, comprising the steps of:
a) selection, from databases of reagents, of those reagents suitable for the desired chemical transformation;
b) distinguishing substituent groups within each reagent structure and calculating the molecular weight and isotope pattern of each substituent group;
c) mapping the substituent groups according to their molecular weight into a chart format following the procedures described herein; and
d) allowing selection of reagents from the charts, either by manual selection or by an automated process according to the Rules defined herein, and subsequent transfer of the reagents to an experimental worksheet for implementation of a manual or automated synthesis ofthe combinatorial library
6. A library of compounds designed and synthesised using the computer-based method of claim 5.
7. Use ofthe computer-based method according to claim 5 for the design and synthesis of a chemical library. A library comprising two or more compounds of formula (E5):
Figure imgf000029_0001
(E5)
where R\ and R2 are as defined in example 5.
7. A library comprising two or more compounds of formula (E6):
Figure imgf000029_0002
where R\ and R2 are as defined in example 6
PCT/EP1996/003731 1995-08-30 1996-08-23 Compounds WO1997008190A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP96930092A EP0852583A2 (en) 1995-08-30 1996-08-23 Compounds
JP9509838A JPH11513027A (en) 1995-08-30 1996-08-23 Compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517661.6A GB9517661D0 (en) 1995-08-30 1995-08-30 Novel compounds
GB9517661.6 1995-08-30

Publications (2)

Publication Number Publication Date
WO1997008190A2 true WO1997008190A2 (en) 1997-03-06
WO1997008190A3 WO1997008190A3 (en) 1997-03-27

Family

ID=10779919

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003731 WO1997008190A2 (en) 1995-08-30 1996-08-23 Compounds

Country Status (4)

Country Link
EP (1) EP0852583A2 (en)
JP (1) JPH11513027A (en)
GB (1) GB9517661D0 (en)
WO (1) WO1997008190A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037953A1 (en) * 1996-04-08 1997-10-16 Glaxo Group Ltd. Mass-based encoding and qualitative analysis of combinatorial libraries
US5908960A (en) * 1997-05-07 1999-06-01 Smithkline Beecham Corporation Compounds
WO1999035109A1 (en) * 1998-01-05 1999-07-15 Neogenesis, Inc. Method for producing mass-coded combinatorial libraries
US6004823A (en) * 1997-05-07 1999-12-21 Smithkline Beecham Corporation Compounds
WO2001057523A1 (en) * 2000-02-03 2001-08-09 Nanoscale Combinatorial Synthesis, Inc. Structure identification methods using mass measurements
JP2002522598A (en) * 1998-08-10 2002-07-23 ザ スクリップス リサーチ インスティテュート Programmable one-pot oligosaccharide synthesis
WO2002095393A2 (en) * 2001-05-24 2002-11-28 National Research Council Of Canada Drug evolution: drug design at hot spots
US6576472B1 (en) 2000-07-26 2003-06-10 Smithkline Beecham Corporation Chemical constructs for solution phase chemistry
US6584411B1 (en) 2000-07-26 2003-06-24 Smithkline Beecham Corporation Methods to facilitate the calculation of yields of reaction products
US6694267B2 (en) 1998-01-05 2004-02-17 Neogenesis Drug Discovery, Inc. Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
EP1728776A2 (en) * 1998-01-05 2006-12-06 Neogenesis, Inc. Method for identifying a member of a mass-coded combinatorial library
US8501498B2 (en) 2004-07-12 2013-08-06 Dh Technologies Development Pte. Ltd. Mass tags for quantitative analyses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
WO1994008051A1 (en) * 1992-10-01 1994-04-14 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
WO1995004160A1 (en) * 1993-07-30 1995-02-09 Isis Innovation Limited Tag reagent and assay method
WO1995019359A1 (en) * 1994-01-12 1995-07-20 Massachusetts Institute Of Technology Process for making xanthene or cubane based compounds, and protease inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
WO1994008051A1 (en) * 1992-10-01 1994-04-14 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
WO1995004160A1 (en) * 1993-07-30 1995-02-09 Isis Innovation Limited Tag reagent and assay method
WO1995019359A1 (en) * 1994-01-12 1995-07-20 Massachusetts Institute Of Technology Process for making xanthene or cubane based compounds, and protease inhibitors

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475807B1 (en) 1996-04-08 2002-11-05 Smithkline Beecham Corporation Mass-based encoding and qualitative analysis of combinatorial libraries
WO1997037953A1 (en) * 1996-04-08 1997-10-16 Glaxo Group Ltd. Mass-based encoding and qualitative analysis of combinatorial libraries
US5908960A (en) * 1997-05-07 1999-06-01 Smithkline Beecham Corporation Compounds
US6004823A (en) * 1997-05-07 1999-12-21 Smithkline Beecham Corporation Compounds
EP1728776A3 (en) * 1998-01-05 2006-12-13 Neogenesis, Inc. Method for identifying a member of a mass-coded combinatorial library
EP1728776A2 (en) * 1998-01-05 2006-12-06 Neogenesis, Inc. Method for identifying a member of a mass-coded combinatorial library
JP2002500205A (en) * 1998-01-05 2002-01-08 ネオジェネシス・インコーポレーテッド Method for producing mass-encoded combinatorial libraries
US6207861B1 (en) 1998-01-05 2001-03-27 Neogenesis, Inc. Method for producing and screening mass coded combinatorial libraries for drug discovery and target validation
JP2011039067A (en) * 1998-01-05 2011-02-24 Neogenesis Inc Manufacturing method of mass coded combinatorial library
EP2241542A1 (en) * 1998-01-05 2010-10-20 Neogenesis, Inc. Apparatus for producing mass-coded combinatorial libraries
EP2241541A1 (en) * 1998-01-05 2010-10-20 Neogenesis, Inc. Method for identifying a member of a mass-coded combinatorial library
US7169563B2 (en) 1998-01-05 2007-01-30 Schering Corporation Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
WO1999035109A1 (en) * 1998-01-05 1999-07-15 Neogenesis, Inc. Method for producing mass-coded combinatorial libraries
US6694267B2 (en) 1998-01-05 2004-02-17 Neogenesis Drug Discovery, Inc. Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
US6714875B1 (en) 1998-01-05 2004-03-30 Neogenesis Drug Discovery, Inc. Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
US6721665B2 (en) 1998-01-05 2004-04-13 Neogenesis Drug Discovery, Inc. Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation
JP2002522598A (en) * 1998-08-10 2002-07-23 ザ スクリップス リサーチ インスティテュート Programmable one-pot oligosaccharide synthesis
US6625546B2 (en) 2000-02-03 2003-09-23 Nanoscale Combinatorial Synthesis, Inc. Structure identification methods using mass measurements
WO2001057523A1 (en) * 2000-02-03 2001-08-09 Nanoscale Combinatorial Synthesis, Inc. Structure identification methods using mass measurements
US6584411B1 (en) 2000-07-26 2003-06-24 Smithkline Beecham Corporation Methods to facilitate the calculation of yields of reaction products
US6576472B1 (en) 2000-07-26 2003-06-10 Smithkline Beecham Corporation Chemical constructs for solution phase chemistry
WO2002095393A3 (en) * 2001-05-24 2003-05-22 Ca Nat Research Council Drug evolution: drug design at hot spots
WO2002095393A2 (en) * 2001-05-24 2002-11-28 National Research Council Of Canada Drug evolution: drug design at hot spots
US8501498B2 (en) 2004-07-12 2013-08-06 Dh Technologies Development Pte. Ltd. Mass tags for quantitative analyses

Also Published As

Publication number Publication date
EP0852583A2 (en) 1998-07-15
WO1997008190A3 (en) 1997-03-27
JPH11513027A (en) 1999-11-09
GB9517661D0 (en) 1995-11-01

Similar Documents

Publication Publication Date Title
Lebl et al. One‐bead–one‐structure combinatorial libraries
Lowe Combinatorial chemistry
US5541061A (en) Methods for screening factorial chemical libraries
EP0863858B1 (en) Mass-based encoding and qualitative analysis of combinatorial libraries
US20030100018A1 (en) Mass-based encoding and qualitative analysis of combinatorial libraries
WO1997008190A2 (en) Compounds
CA2118806A1 (en) Method of synthesizing diverse collections of oligomers
WO1995032425A1 (en) Encoded combinatorial libraries
AU2292695A (en) Complex combinatorial chemical libraries encoded with tags
US6207861B1 (en) Method for producing and screening mass coded combinatorial libraries for drug discovery and target validation
US6210900B1 (en) Method of encoding a series of combinatorial libraries and developing structure activity relationships
EP0675873A1 (en) Synthesis of encoded polymers
US6503759B1 (en) Complex combinatorial chemical libraries encoded with tags
JP2011039067A (en) Manufacturing method of mass coded combinatorial library
Williard et al. Combinatorial chemistry: a rational approach to chemical diversity
Southern High-density gridding: techniques and applications
WO1996023749A1 (en) Chemical libraries, labelling and deconvolution thereof
JP2002541226A (en) Code scheme for solid-phase chemical libraries
Lebl et al. Felder zyxwvutsrqponmlkj
Kushwaha et al. A Novel Methods Used in Drug Discovery
Ambre et al. Combinatorial Chemistry: Role in Lead Discovery
EP1728776A2 (en) Method for identifying a member of a mass-coded combinatorial library
Ferguson Design, synthesis and biological screening of combinatorial chemical libraries
WO1997029371A1 (en) Sulfur ratio tagging method for combinatorial libraries
WO2006018277A1 (en) Method for rational combinatorial synthesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996930092

Country of ref document: EP

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 1997 509838

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996930092

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996930092

Country of ref document: EP